News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New medicines improve options for respiratory conditions

Media release

New medicine listings improve treatment options for people with respiratory conditions

PHARMAC decisions to fund four new medicines will improve treatment options for over 10,000 people with a wide range of respiratory conditions.

From 1 November 2014 funding will be available for two medicines, glycopyrronium and indacaterol for chronic obstructive pulmonary disease (COPD), omalizumab for severe allergic asthma, and an inhalation form of the antibiotic tobramycin for cystic fibrosis.

Director of Operations Sarah Fitt says there are currently limited medicine options for these conditions. Having further choice is likely to be welcomed by patients and clinicians, and lead to better outcomes.

“For example, patients with the more severe forms of allergic asthma are often admitted to hospital for treatment. Omalizumab is a new generation treatment for this form of asthma. It’s an injection that’s shown to be particularly effective in allergic asthma, and would likely help patients with the most severe forms better control their symptoms and avoid regular hospital treatment. About 180 patients over five years are likely to use omalizumab”.

At present only one medicine – tiotropium – is funded specifically for COPD.

“Having two further funded treatments specifically registered for the treatment of COPD symptoms provides greater choice and the ability to tailor treatment to the patient,” says Sarah Fitt.

PHARMAC estimates about 10,000 patients could benefit from these new COPD medicines over five years.

The inhalation form of tobramycin contains no preservatives and is specifically formulated for inhalation, which makes it more suitable for patients, she says.

The medicines have been funded as part of a major multi-product agreement with pharmaceutical company Novartis.

ENDS


© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Facebook Announces New Changes: Combating Hate And Extremism

Some of these changes predate the tragic terrorist attack in Christchurch, New Zealand, but that attack, and the global response to it in the form of the Christchurch Call to Action, has strongly influenced the recent updates to our policies and their enforcement. More>>

Amazon Confirms: Lord Of The Rings Series To Shoot In NZ

Amazon Studios announced today that its series based on J.R.R. Tolkien’s iconic fantasy novels The Lord of the Rings will shoot in New Zealand. Pre-production has started, and production on the series will begin in Auckland in the coming months. More>>

ALSO:

Birds: Dunedin's Bells Ring As City Celebrates Its Albatross

The city's churches, schools and public buildings bells would chime in unison from 1pm, in what has been a long-standing tradition marking the return of the birds - and a farewell to this season's albatross chicks. More>>

Oscar Buzz: Waititi's Jojo Rabbit Wins People's Choice Award At Toronto

Taika Waititi's new film Jojo Rabbit has nabbed the coveted Grolsch People's Choice Award at the close of Toronto International Film Festival. More>>

ALSO:

Broken Estate: An Expat Expert Surveys Our Media

Melanie Bunce cut her teeth in journalism at the Otago Daily Times. Now she teaches and researches it at one of the UK’s most prestigious journalism schools and tracks the trends that shape the uncertain future of news... More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland